Essential Pharmacy Compounding LLC

Form 483 issued July 23, 2015 · Omaha, Nebraska

Inspection
May 13, 2020
Observations
12
Pages
7
FEI number
3003718003

In short: On July 23, 2015, FDA issued a Form 483 with 12 observations to Essential Pharmacy Compounding LLC in Omaha, Nebraska (FEI 3003718003) after an inspection that ran May 13, 2020. The investigators were Eric M. Mueller, Jenny Agila Sefen and Joseph R. Lambert. Most observations concern facilities & equipment and quality system.

At a glance

Observations span 4 systems, led by facilities & equipment.

Facilities & equipment3
Quality system3
Production2
Materials2
Other2

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Procedures designed to prevent microbiological contamination of drug products purporting to be sterile do not include…

  2. 02

    Clothing of personnel engaged in the processing of drug products is not appropriate for…

  3. 03

    Aseptic processing areas are deficient regarding the system…

  4. 04

    There is a failure to thoroughly review any unexplained discrepancy whether or not the batch…

8 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Essential Pharmacy Compounding LLC?

FDA listed 12 observations on this Form 483, mostly about facilities & equipment, quality system and production. The opening words of each observation are shown on this page.

Who inspected Essential Pharmacy Compounding LLC?

Eric M. Mueller, Jenny Agila Sefen and Joseph R. Lambert are named on this Form 483, for the inspection of May 13, 2020. Each investigator has a profile showing what they cite most.

When was Essential Pharmacy Compounding LLC inspected by FDA?

The inspection ran May 13, 2020, and the Form 483 is dated July 23, 2015.

How do I get the full Form 483 for Essential Pharmacy Compounding LLC?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free